Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03744871
Other study ID # 03-18-20
Secondary ID R01ES019616
Status Completed
Phase N/A
First received
Last updated
Start date March 22, 2019
Est. completion date July 31, 2023

Study information

Verified date December 2023
Source University Hospitals Cleveland Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Fine particulate matter < 2.5 microns (PM2.5) air pollution is a leading global risk factor for cardiovascular morbidity and mortality. PM2.5 presents a serious ongoing public health threat to patients living in highly-polluted countries (ex: China, India) where air quality is projected to remain extremely poor (far exceeding World Health Organization Air Quality Guidelines) for the foreseeable future. This study reviews the benefits of personal level intervention (wearing N95 respirator) over long term, to prevent clinical events among patients with cardiovascular disease.


Description:

CLEANAIR-ACS will be an investigation within ASPIRE, that will test the ability of personal-level intervention (N95 respirators) to improve validated surrogate markers of cardio-metabolic health in patients with a recent Acute Coronary Syndrome (ACS). Patients with ACS are a vulnerable patient population with vulnerability and at risk for future cardiovascular events. This vanguard phase study in Beijing involving patients exposed to high levels of air pollution who have recently sustained an ACS event, is necessary to obtain feasibility data and gather a battery of information allowing for the appropriate design of a larger clinical outcome trial. What is more, positive results would provide critically-important information demonstrating for the first time that it is feasible to "prescribe" the use of these personal protection devices to cardiac patients, and that their usage is capable of translating into demonstrable health benefits (i.e., improved BP and insulin sensitivity) over the long-term. The study hypothesis is that long-term personal-level interventions to reduce exposure to PM2.5 can be feasibly performed for 1-year post-acute coronary syndrome (ACS) and will result in significant improvements in validated surrogate cardiometabolic endpoints predictive of morbidity/mortality.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date July 31, 2023
Est. primary completion date July 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Male or female >18, able to provide informed consent and willingness to complete the study protocol and measurement procedures, AND 2. Non-smoker of any type (cigarette, cigar, marijuana) during past six months (100% abstinence per self-report) and living in a non-smoking household (no person living in the household smoking at home) with confirmation of non-smoking status by urinary cotinine levels. AND 3. A diagnosis of myocardial infarction or unstable angina 7-90 days prior to signed informed consent Exclusion Criteria: 1. Inability for mental or physical reasons to understand and comply with the informed consent process and/or the study protocol procedures including wearing face mask (i.e: advanced COPD/lung disease requiring use of frequent inhalational or nebulizer treatments) per investigator discretion. 2. Obesity with arm circumference >18 inches preventing accurate BP determination during ABPM monitoring 3. Significant hemodynamically unstable CV disorder including uncompensated heart failure, refractory angina, uncontrolled arrhythmias, critical valvular heart disease and severe hypertension. (as further described in Appendix B) at screening 4. ESRD on dialysis or patients that have received dialysis within 14 days prior to screening 5. Subject has a history of infection with human immunodeficiency virus 6. Subject has a history of alcohol or substance abuse within the 6 months prior to the screening 7. Advanced COPD on home oxygen 8. Past diagnosis of sleep apnea either untreated or treated with CPAP 9. History of malignancy including leukemia and lymphoma (but not basal cell skin cancer, cured squamous cell cancer and localized Prostate cancer) AND/OR any severe, life-threatening disease AND/OR history of drug abuse within the last 2 years 10. Regular use of any over-the-counter drug, recreational medication including stimulants (amphetamines) and/or complimentary or herbal therapy that might impact study outcomes including BP and insulin sensitivity per investigator discretion. 11. In women of childbearing age: pregnancy, non-use of approved method of birth control, intent to get pregnant during the study period 12. Patients with passive home cigarette smoking 13. Other medical or psychosocial conditions or life circumstances that may put the subject at increased risk of participation or jeopardizes the scientific integrity of the study, as determined by the investigators -

Study Design


Related Conditions & MeSH terms


Intervention

Other:
N95 Respirator
SiTi N95 respirator with microventilator (change twice weekly and earlier as needed).

Locations

Country Name City State
China Peking University Beijing
United States University Hospitals Cleveland Medical Center Cleveland Ohio

Sponsors (3)

Lead Sponsor Collaborator
University Hospitals Cleveland Medical Center Peking University, University of Michigan

Countries where clinical trial is conducted

United States,  China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Blood Pressure Use Omron 907xl for clinic BP Measures, with 3 repeated measurements after 5 minutes after clinicians leave room (patient unattended). Averages of the 3 BP Recordings will be obtained 12 months
Secondary PWV and pulse wave analysis To be measured at clinic visits, with Omron used in JI Study 12 months
Secondary BP/HRV Monitoring 24 hour ambulatory HRV/BP will be placed when clinic BP is complete as the first clinic measure. The monitoring systems have been used in JI study previously 12 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04830059 - The Joint Effect of Air Pollution and Exercise on Cognitive Function N/A
Completed NCT02252302 - Exercise in Air Pollution and Lung Health in Asthmatics N/A
Recruiting NCT05323240 - Health Effects of Repeated Exposure to Low Levels of Concentrated Ambient Particles in Healthy Young Volunteers N/A
Completed NCT03187704 - Boston Puerto Rican Health Study N/A
Completed NCT03083067 - Salvational Intervention for Reducing AECOPD Under Severe Air Pollution N/A
Recruiting NCT05718245 - HEPA, PM2.5, and Cardiometabolic Health N/A
Completed NCT04029129 - Reducing Traffic Pollution Exposure Improves Blood Pressure N/A
Recruiting NCT05423665 - Speckle Tracking Echocardiography as a Tool for Early Diagnosis of Impaired Fetal Growth Twin Pregnancies
Recruiting NCT05570552 - 1/2- Bangladesh Center for Global Environmental and Occupational Health- Bangladesh N/A
Recruiting NCT05867381 - Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History N/A
Completed NCT03301519 - Genetics of Beta Cell Failure in Mexican Americans
Enrolling by invitation NCT02652182 - Short-term Air Pollution Exposure and In-hospital Outcomes in Patients With Acute Myocardial Infraction N/A
Recruiting NCT04662047 - The Impact of Air Pollution on the Consumption of Antimicrobials in the General Population
Recruiting NCT05794087 - The Role of Macrophage Activation in Lung Injury Following Ozone Exposure N/A
Recruiting NCT04725734 - Air Pollution and Daily Mobility of Pregnant Women Identification of Critical Windows of Exposure
Completed NCT02673775 - Air Pollution Study: The Effect of Ozone on the Lung N/A
Completed NCT02027415 - The Effect of Juice Types on the Responses to Air Pollution N/A
Completed NCT00808912 - Does Sildenafil Increase Exercise Performance in Air Pollution? N/A
Completed NCT04539925 - Air Pollution Exposure on Acute Coronary Syndrome in Two Cohorts of Industrial and Non-industrial Areas
Enrolling by invitation NCT05843370 - Modification of Ambient Air Pollution Exposure and Cardiopulmonary Outcomes by Socioeconomic Status and Nutrition